Published in Ann Intern Med on April 01, 1984
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis (2012) 0.97
Heparin-induced thrombocytopenia in the pediatric population: a review of current literature. J Pediatr Pharmacol Ther (2012) 0.93
Adrenal apoplexy after coronary artery bypass surgery leading to Addisonian crisis. J R Soc Med (1992) 0.91
Heparin-associated skin necrosis. Postgrad Med J (1990) 0.88
Adrenal apoplexy--the silent killer. J R Soc Med (1993) 0.84
Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg (2009) 0.83
Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis. J Gen Intern Med (2000) 0.82
Effect of oral administration of aqueous whole extract of cassytha filiformis on haematograms and plasma biochemical parameters in rats. J Med Toxicol (2007) 0.82
Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis. Transfusion (2010) 0.79
Treatment of the heparin-induced thrombosis-thrombocytopenia syndrome by very low dose streptokinase. Heart (1996) 0.75
Laboratory evaluation of a bleeding patient. West J Med (1989) 0.75
Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia. Hosp Pract (1995) (2010) 0.75
The emergency use of recombinant hirudin in cardiopulmonary bypass. 1999. J Extra Corpor Technol (2005) 0.75
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood (1996) 7.31
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med (1995) 6.86
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med (1991) 4.66
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med (1998) 3.18
Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med (2001) 2.89
Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood (2000) 2.78
Topography of visual cortex connections with frontal eye field in macaque: convergence and segregation of processing streams. J Neurosci (1995) 2.68
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood (1991) 2.54
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost (2015) 2.46
A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol (1992) 2.18
The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med (1994) 2.09
Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med (1993) 2.08
Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. Br J Haematol (1995) 2.07
High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med (1997) 2.05
A 14-year study of heparin-induced thrombocytopenia. Am J Med (1996) 2.03
Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol (1999) 2.02
A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol (1995) 2.01
The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med (1997) 2.00
Saccade target selection in frontal eye field of macaque. I. Visual and premovement activation. J Neurosci (1995) 1.90
Bone marrow transplantation. BMJ (1995) 1.83
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost (2008) 1.75
Clinical chemical values for some common laboratory animals. Clin Chem (1980) 1.71
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation (2001) 1.64
Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis. J Clin Microbiol (1995) 1.58
A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion (1993) 1.52
Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia. J Lab Clin Med (1997) 1.51
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol (1993) 1.50
Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Ann Intern Med (1996) 1.48
Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol (1990) 1.43
Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity. J Clin Invest (1978) 1.43
A novel congenital haemostatic defect: combined factor VII and factor XI deficiency. Blood Coagul Fibrinolysis (1992) 1.42
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res (1996) 1.42
Are we as depressed as we think we are? Ulster Med J (1977) 1.40
Tardive dystonia. The benefits of time. Br J Psychiatry (1989) 1.40
Phylogenetic relationships among highly virulent Newcastle disease virus isolates obtained from exotic birds and poultry from 1989 to 1996. J Clin Microbiol (1998) 1.39
A Canadian hospital-based HIV/hepatitis C look-back notification program. CMAJ (1997) 1.38
The avian response to Newcastle disease virus. Dev Comp Immunol (2000) 1.35
Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med (2001) 1.30
Immune-mediated thrombocytopenia of malaria. J Clin Invest (1983) 1.28
A diagnostic test for heparin-induced thrombocytopenia. Blood (1986) 1.27
Gestational thrombocytopenia. Clin Obstet Gynecol (1999) 1.24
A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood (1982) 1.21
Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol (2000) 1.19
Obstructive jaundice. An unusual presentation of granulocytic sarcoma. Cancer (1987) 1.17
Control of Newcastle disease by vaccination. Dev Biol (Basel) (2004) 1.17
A herpesvirus isolated from kidney cell culture of normal turkeys. Avian Dis (1969) 1.15
Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood (1981) 1.14
Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol (1990) 1.12
Infection-induced thrombocytopenia. Semin Thromb Hemost (1982) 1.10
A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost (2013) 1.10
Site-specific attachment to recombinant antibodies via introduced surface cysteine residues. Protein Eng (1990) 1.10
Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Dis (2003) 1.10
The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood (1982) 1.10
Evaluation of the hemagglutination-inhibition test for measuring the response of chickens to avian infectious bronchitis virus vaccination. Avian Dis (1983) 1.09
Clinical impact of neonatal thrombocytopenia. J Pediatr (1987) 1.09
Heparin-induced thrombocytopenia. Annu Rev Med (1989) 1.08
A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol (1999) 1.08
Autoimmune platelet destruction: idiopathic thrombocytopenic purpura. Semin Thromb Hemost (1982) 1.07
Elevated platelet-associated IgG in the thrombocytopenia of septicemia. N Engl J Med (1979) 1.06
Vaccination-Associated relapse of immune thrombocytopenia. JAMA (1981) 1.06
The direct assay for platelet-associated IgG (PAIgG): lack of association between antibody level and platelet size. Blood (1979) 1.05
Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet (1992) 1.05
Virulence of pigeon-origin Newcastle disease virus isolates for domestic chickens. Avian Dis (2002) 1.05
Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv (1993) 1.04
Digitalis toxicity manifested by dysphagia. JAMA (1978) 1.02
Molecular evolution of the Newcastle disease virus matrix protein gene and phylogenetic relationships among the paramyxoviridae. Virus Res (2000) 1.02
The use of in vitro technics to study drug-induced pancytopenia. N Engl J Med (1979) 1.01
Heparin-induced thrombocytopenia. Prog Hemost Thromb (1991) 1.01
IMBA Expert: internal dosimetry made simple. Radiat Prot Dosimetry (2003) 1.01
Tranquillisers and plasma prolactin. Br Med J (1979) 1.01
Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med (1988) 1.00
Neonatal thrombocytopenia due to passive immunization: prenatal diagnosis and distinction between maternal platelet alloantibodies and autoantibodies. N Engl J Med (1980) 1.00
VL:VH domain rotations in engineered antibodies: crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs. Proteins (1997) 1.00
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood (2000) 1.00
Heparin and platelets. Hematol Oncol Clin North Am (1990) 0.99
Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. Br J Haematol (1999) 0.99
Bleeding associated with antithrombotic therapy. Semin Hematol (1980) 0.98
Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Schizophr Res (2000) 0.98
Pathogenesis of six pigeon-origin isolates of Newcastle disease virus for domestic chickens. Vet Pathol (2002) 0.98
Antiplatelet agents: rationale and results. Clin Haematol (1983) 0.98
Comparison of chemical composition of peritoneal fluid and serum: a method for monitoring dialysis patients and a tool for assessing binding to serum proteins in vivo. Ann Intern Med (1978) 0.97
Experimental pathogenesis for chickens, turkeys, and pigeons of exotic Newcastle disease virus from an outbreak in California during 2002-2003. Vet Pathol (2006) 0.97
Isotype choice for chimeric antibodies affects binding properties. J Biol Chem (1994) 0.97
trans Fatty acids in human milk are inversely associated with concentrations of essential all-cis n-6 and n-3 fatty acids and determine trans, but not n-6 and n-3, fatty acids in plasma lipids of breast-fed infants. Am J Clin Nutr (1999) 0.96
Matrix-assisted UV-laser desorption/ionization mass spectrometric analysis of monoclonal antibodies for the determination of carbohydrate, conjugated chelator, and conjugated drug content. Anal Chem (1991) 0.96
Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. Protein Eng (1994) 0.95
Splenectomy in the management of haematological disease. Br J Surg (1987) 0.94
Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim Biophys Acta (1987) 0.94
Characterization of a battery of monoclonal antibodies for differentiation of Newcastle disease virus and pigeon paramyxovirus-1 strains. Avian Dis (1988) 0.94
Patterns in drug utilization--national and international aspects: psychoactive drugs 1966-80. Acta Med Scand Suppl (1984) 0.94
Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood (1980) 0.94
Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management. Blood Rev (1996) 0.94
Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood (2001) 0.94
Psychotropic drug use in Northern Ireland 1966-80: prescribing trends, inter- and intra-regional comparisons and relationship to demographic and socioeconomic variables. Psychol Med (1982) 0.93
Newcastle disease virus phosphoprotein gene analysis and transcriptional editing in avian cells. Virus Res (2000) 0.92
Use of a heteroduplex mobility assay to detect differences in the fusion protein cleavage site coding sequence among Newcastle disease virus isolates. J Clin Microbiol (2001) 0.91
The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol (1996) 0.90
p-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem (1991) 0.90